Annual FCF
-$150.08 M
-$40.18 M-36.56%
31 December 2023
Summary:
Day One Biopharmaceuticals annual free cash flow is currently -$150.08 million, with the most recent change of -$40.18 million (-36.56%) on 31 December 2023. During the last 3 years, it has fallen by -$136.50 million (-1005.05%). DAWN annual FCF is now -3223.96% below its all-time high of -$4.51 million, reached on 31 December 2019.DAWN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$4.97 M
+$61.28 M+92.50%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly free cash flow is currently -$4.97 million, with the most recent change of +$61.28 million (+92.50%) on 30 September 2024. Over the past year, it has increased by +$35.13 million (+87.61%). DAWN quarterly FCF is now -162.60% below its all-time high of -$1.89 million, reached on 30 June 2020.DAWN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$162.34 M
+$35.13 M+17.79%
30 September 2024
Summary:
Day One Biopharmaceuticals TTM free cash flow is currently -$162.34 million, with the most recent change of +$35.13 million (+17.79%) on 30 September 2024. Over the past year, it has dropped by -$18.33 million (-12.73%). DAWN TTM FCF is now -7370.55% below its all-time high of -$2.17 million, reached on 31 March 2020.DAWN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.6% | +87.6% | -12.7% |
| 3 y3 years | -1005.0% | +59.3% | -229.2% |
| 5 y5 years | - | - | - |
DAWN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1005.0% | at low | at high | +92.5% | -229.2% | +17.8% |
| 5 y | 5 years | -3224.0% | at low | -162.6% | +92.5% | -7370.6% | +17.8% |
| alltime | all time | -3224.0% | at low | -162.6% | +92.5% | -7370.6% | +17.8% |
Day One Biopharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.97 M(-92.5%) | -$162.34 M(-17.8%) |
| June 2024 | - | -$66.25 M(+33.2%) | -$197.47 M(+13.6%) |
| Mar 2024 | - | -$49.73 M(+20.2%) | -$173.79 M(+15.8%) |
| Dec 2023 | -$150.08 M(+36.6%) | -$41.38 M(+3.2%) | -$150.08 M(+4.2%) |
| Sept 2023 | - | -$40.10 M(-5.8%) | -$144.01 M(+13.3%) |
| June 2023 | - | -$42.58 M(+63.7%) | -$127.12 M(+11.2%) |
| Mar 2023 | - | -$26.01 M(-26.3%) | -$114.33 M(+4.0%) |
| Dec 2022 | -$109.90 M | -$35.31 M(+52.1%) | -$109.90 M(+25.2%) |
| Sept 2022 | - | -$23.22 M(-22.1%) | -$87.76 M(+14.3%) |
| June 2022 | - | -$29.79 M(+38.1%) | -$76.76 M(+27.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$21.58 M(+63.9%) | -$60.37 M(+6.8%) |
| Dec 2021 | -$56.54 M(+316.3%) | -$13.17 M(+7.8%) | -$56.54 M(+14.7%) |
| Sept 2021 | - | -$12.22 M(-8.8%) | -$49.31 M(+21.3%) |
| June 2021 | - | -$13.41 M(-24.4%) | -$40.66 M(+39.5%) |
| Mar 2021 | - | -$17.74 M(+198.9%) | -$29.15 M(+114.6%) |
| Dec 2020 | -$13.58 M(+200.8%) | -$5.94 M(+65.9%) | -$13.58 M(+77.7%) |
| Sept 2020 | - | -$3.58 M(+89.0%) | -$7.64 M(+88.0%) |
| June 2020 | - | -$1.89 M(-12.9%) | -$4.07 M(+87.1%) |
| Mar 2020 | - | -$2.17 M | -$2.17 M |
| Dec 2019 | -$4.51 M | - | - |
FAQ
- What is Day One Biopharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual FCF year-on-year change?
- What is Day One Biopharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly FCF year-on-year change?
- What is Day One Biopharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM FCF year-on-year change?
What is Day One Biopharmaceuticals annual free cash flow?
The current annual FCF of DAWN is -$150.08 M
What is the all time high annual FCF for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual free cash flow is -$4.51 M
What is Day One Biopharmaceuticals annual FCF year-on-year change?
Over the past year, DAWN annual free cash flow has changed by -$40.18 M (-36.56%)
What is Day One Biopharmaceuticals quarterly free cash flow?
The current quarterly FCF of DAWN is -$4.97 M
What is the all time high quarterly FCF for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly free cash flow is -$1.89 M
What is Day One Biopharmaceuticals quarterly FCF year-on-year change?
Over the past year, DAWN quarterly free cash flow has changed by +$35.13 M (+87.61%)
What is Day One Biopharmaceuticals TTM free cash flow?
The current TTM FCF of DAWN is -$162.34 M
What is the all time high TTM FCF for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM free cash flow is -$2.17 M
What is Day One Biopharmaceuticals TTM FCF year-on-year change?
Over the past year, DAWN TTM free cash flow has changed by -$18.33 M (-12.73%)